2614W94;Phenoxathiin, 3-(2,2,2-trifluoro-1-methylethoxy)-, 10,10-dioxide;2614W-94,2614W94;2614W94, 10 mM in DMSO;3-(1,1,1-Trifluoropropan-2-yloxy)phenoxathiine 10,10-dioxide
2614W94 is a selective and reversible monoamine oxidase-A (MAO-A) inhibitor used for studying MAO-A-related neurological and psychiatric disorders; it selectively inhibits MAO-A in the brain and liver, increases levels of neurotransmitter amines such as serotonin and norepinephrine, and potentiates 5-hydroxytryptophan-induced head twitches in rats, indicating its potential application in antidepressant research and development.